SCHEMBL6007654

SCHEMBL6007654

COc1cc2c(cc1OC)CN(C(=O)[C@@H]1CCCN(CCN3C(=O)c4ccccc4C3=O)C1)CC2

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
KMT2A Q03164 4/20 0.58
MEN1 O00255 1/20 0.58
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
KDM4E B2RXH2 3/20 0.49
TDP1 Q9NUW8 2/20 0.49
GAA P10253 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
POLB P06746 1/20 0.47
NPC1 O15118 1/20 0.46
ATM Q13315 1/20 0.46
PDE4B Q07343 3/20 0.46
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ABCB1 P08183 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6009599 0.83 KMT2A (0.58) ALDH1A1KMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL6009608 0.83 KMT2A (0.58) ALDH1A1KMT2AMEN1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL10338896 0.80 KMT2A (0.60) ALDH1A1KMT2AMEN1SMN1; SMN2KDM4E
SCHEMBL6589156 0.79 ALDH1A1 (0.62) ALDH1A1KMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL27855133 0.78 ALDH1A1 (0.65) ALDH1A1ABCB1
Hydrochloric Acid SCHEMBL6586295 0.77 KMT2A (0.54) KMT2AMEN1SMN1; SMN2POLBPDE4B
SCHEMBL6587045 0.77 DRD4 (0.57) KMT2AMEN1PDE4B
Hydrochloric Acid SCHEMBL6589249 0.77 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL3991771 0.76 DRD3 (0.55) ALDH1A1KMT2AMEN1GAAPOLB
SCHEMBL6587232 0.76 SIGMAR1 (0.51) KMT2AMEN1PDE4BABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084807-A1 Novel denzamide derivatives and process for production thereof ASTELLAS PHARMA INC. (JP) 2006-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084807-A1 Novel denzamide derivatives and process for production thereof NNMT, SCN5A, QDPR ALDH1A1 1170/4885KMT2A 483/4885MEN1 3449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.